Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mette Haugen

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Frontiers in Neurology|October 11, 2021
CRMP5 Antibodies-Diagnostic ChallengesCecilie Totland, Mette Haugen, Christian Vedeler
Journal of Neurology, Neurosurgery, and Psychiatry|April 19, 2013
Neurological manifestations related to level of voltage-gated potassium channel antibodiesHenning Olberg, Mette Haugen, Anette Storstein, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 11, 2025
Magne Solberg Nes, Jogrim Søyland, Mette Haugen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 3, 2021
Paraneoplastic Cerebellar Degeneration: The Importance of Including CDR2L as a Diagnostic MarkerIda Herdlevær, Mette Haugen, Kibret Mazengia, et al.
Journal of Neuroimmunology|November 25, 2021
Expression of cerebellar degeneration-related proteins CDR2 and CDR2L in human and rat brain tissueMargrethe Raspotnig, Torbjørn Kråkenes, Ida Herdlevær, et al.
Oncotarget|May 31, 2018
Expression of the onconeural protein CDR1 in cerebellum and ovarian cancerCecilie Totland, Torbjørn Kråkenes, Kibret Mazengia, et al.
Annals of Neurology|May 24, 2020
Reply to "CDR2 and CDR2L Yo Antigens in Paraneoplastic Cerebellar Degeneration"Torbjørn Kråkenes, Ida Herdlevaer, Margrethe Raspotnig, et al.
Cancer Immunology, Immunotherapy : CII|August 15, 2009
Antibody to CCDC104 is associated with a paraneoplastic antibody to CDR2 (anti-Yo)Cecilie Totland, Geir Bredholt, Mette Haugen, et al.
Acta Neuropathologica|October 25, 2014
Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasisManja Schubert, Debabrata Panja, Mette Haugen, et al.
European Journal of Neurology|March 13, 2023
A cerebellar degeneration-related protein 2-like cell-based assay for anti-Yo detection in patients with paraneoplastic cerebellar degenerationKjell Inge Erikstad, Ida Herdlevaer, Elise Peter, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Frontiers in Neurology|October 11, 2021
CRMP5 Antibodies-Diagnostic ChallengesCecilie Totland, Mette Haugen, Christian Vedeler
Journal of Neurology, Neurosurgery, and Psychiatry|April 19, 2013
Neurological manifestations related to level of voltage-gated potassium channel antibodiesHenning Olberg, Mette Haugen, Anette Storstein, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 11, 2025
Magne Solberg Nes, Jogrim Søyland, Mette Haugen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 3, 2021
Paraneoplastic Cerebellar Degeneration: The Importance of Including CDR2L as a Diagnostic MarkerIda Herdlevær, Mette Haugen, Kibret Mazengia, et al.
Journal of Neuroimmunology|November 25, 2021
Expression of cerebellar degeneration-related proteins CDR2 and CDR2L in human and rat brain tissueMargrethe Raspotnig, Torbjørn Kråkenes, Ida Herdlevær, et al.
Oncotarget|May 31, 2018
Expression of the onconeural protein CDR1 in cerebellum and ovarian cancerCecilie Totland, Torbjørn Kråkenes, Kibret Mazengia, et al.
Annals of Neurology|May 24, 2020
Reply to "CDR2 and CDR2L Yo Antigens in Paraneoplastic Cerebellar Degeneration"Torbjørn Kråkenes, Ida Herdlevaer, Margrethe Raspotnig, et al.
Cancer Immunology, Immunotherapy : CII|August 15, 2009
Antibody to CCDC104 is associated with a paraneoplastic antibody to CDR2 (anti-Yo)Cecilie Totland, Geir Bredholt, Mette Haugen, et al.
Acta Neuropathologica|October 25, 2014
Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasisManja Schubert, Debabrata Panja, Mette Haugen, et al.
European Journal of Neurology|March 13, 2023
A cerebellar degeneration-related protein 2-like cell-based assay for anti-Yo detection in patients with paraneoplastic cerebellar degenerationKjell Inge Erikstad, Ida Herdlevaer, Elise Peter, et al.
Pageof 2